EGFR and lung cancer: In conclusion, our findings demonstrated that lung cancer in younger patients (≦ 45 years) has unique characteristics, with a greater proportion of female patients, adenocarcinoma, and never-smokers, and a lower EGFR mutation rate compared with older patients.